Paper 125: Use of Ad-Osf2 Modified Adipose-derived Stem Cells to Enhance Tendon-Bone Integration in the Reconstruction of ACL

Xin Zhang,Yingfang AO,Yong Ma
DOI: https://doi.org/10.1016/j.arthro.2012.05.608
2012-01-01
Abstract:To determine the efficacy of using Ad-Osf2 modified adipose-derived stem cells to enhance tendon-to-bone healing. ADSCs were harvested from SD rats and transduced with adenovirus carrying the recombinant mouse Osf2 gene. Untransduced cells and cells transduced with adenovirus carrying the enhanced green fluorescence protein (Ad-EGFP) gene served as controls. Osf2 expression was assessed by realtime -PCR, immunofluorescence, and Western blot. Alkaline phosphatase (ALP) activity was assayed on days 1,3,7, 10 and 14. Osteocalcin production and bone nodule formation were detected by von Kossa stain on day 7,10,14,21. A total of 1×106 cells mixed with PLA were implanted into the subcutaneous pocket in nude mouse and subjected to histological analysis 4 weeks post-implantation. The semitendinosus tendons were translated into 2.5-mm diameter bone tunnels in a New Zealand white rabbit model of ACL reconstruction. The bone tunnels were treated with or without Ad-Osf2-ADSCs. Three specimens were harvested at 3,6,12, 24 and 52 weeks postoperatively and evaluated by radiological, histological, immunohistochemical and biomechanical methods. Overexpression of Osf2 inhibited adipogenesis, as demonstrated by suppression of LPL and PPAR? expression at the mRNA level and reduced lipid droplet formation. Moreover, ADSCs transduced with Ad- Osf2 underwent rapid and marked osteoblast differentiation as determined by osteoblastic gene expression, alkaline phosphatase activity and mineral deposition. Additionally, histological examination revealed that implantation of Osf2 modified ADSCs could induce mineral deposition and bone-like tissue formation in vivo. In animal model of ACL reconstruction, CT show bone formation and remodeling around the bone tunnel were significantly enhanced in the group treated with Osf2 modified ADSCs. Histologic examination demonstrated more extensive bone formation around the tendon, with closer apposition of new bone to the tendon in knees treated with Osf2 compared with control knees. Biomechanical testing demonstrated higher tendon pullout strength in the Osf2 site at all time points. Firstly, Osf2 can promote ADSCs osteogenesis in vtro and in vivo; Secondly, Osf2 modified adipose-derived stem cells can promote the healing of tendon graft-to-bone.
What problem does this paper attempt to address?